These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 33015675)

  • 21. Intensifying vaccine production.
    Bull World Health Organ; 2020 May; 98(5):302-303. PubMed ID: 32514194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 23. Audio Interview: Covid-19 Vaccine Development.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(3):e40. PubMed ID: 32668131
    [No Abstract]   [Full Text] [Related]  

  • 24. COVID-19 and mRNA Vaccines-First Large Test for a New Approach.
    Abbasi J
    JAMA; 2020 Sep; 324(12):1125-1127. PubMed ID: 32880613
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19 vaccine development pipeline gears up.
    Mullard A
    Lancet; 2020 Jun; 395(10239):1751-1752. PubMed ID: 32505245
    [No Abstract]   [Full Text] [Related]  

  • 26. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
    Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
    Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 vaccines for all?
    Usher AD
    Lancet; 2020 Jun; 395(10240):1822-1823. PubMed ID: 32534638
    [No Abstract]   [Full Text] [Related]  

  • 28. A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.
    Hanley BP; Keen S; Church G
    Rejuvenation Res; 2020 Aug; 23(4):281-283. PubMed ID: 32539623
    [No Abstract]   [Full Text] [Related]  

  • 29. An Inactivated Virus Candidate Vaccine to Prevent COVID-19.
    Mulligan MJ
    JAMA; 2020 Sep; 324(10):943-945. PubMed ID: 32789500
    [No Abstract]   [Full Text] [Related]  

  • 30. Privileges and Immunity Certification During the COVID-19 Pandemic.
    Hall MA; Studdert DM
    JAMA; 2020 Jun; 323(22):2243-2244. PubMed ID: 32374358
    [No Abstract]   [Full Text] [Related]  

  • 31. Understanding COVID-19 vaccine efficacy.
    Lipsitch M; Dean NE
    Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 vaccines and neglected pregnancy.
    Dashraath P; Nielsen-Saines K; Madhi SA; Baud D
    Lancet; 2020 Sep; 396(10252):e22. PubMed ID: 32861313
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 vaccines: early success and remaining challenges.
    Bar-Zeev N; Inglesby T
    Lancet; 2020 Sep; 396(10255):868-869. PubMed ID: 32896290
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
    Schwartz JL
    N Engl J Med; 2020 Oct; 383(18):1703-1705. PubMed ID: 32966716
    [No Abstract]   [Full Text] [Related]  

  • 35. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
    Palatnik-de-Sousa CB
    Front Immunol; 2020; 11():2173. PubMed ID: 32983183
    [No Abstract]   [Full Text] [Related]  

  • 36. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [COVID-19: Impact of a pandemic].
    Cuestas ML; Minassian ML
    Rev Argent Microbiol; 2020; 52(3):167-168. PubMed ID: 33032744
    [No Abstract]   [Full Text] [Related]  

  • 38. Global governance for COVID-19 vaccines.
    The Lancet
    Lancet; 2020 Jun; 395(10241):1883. PubMed ID: 32563355
    [No Abstract]   [Full Text] [Related]  

  • 39. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Russian SARS-CoV-2 vaccine.
    Caddy S
    BMJ; 2020 Aug; 370():m3270. PubMed ID: 32839191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.